170 related articles for article (PubMed ID: 38203692)
1. Comprehensive Analysis of MICALL2 Reveals Its Potential Roles in EGFR Stabilization and Ovarian Cancer Cell Invasion.
Xia T; Ye F; Zhao W; Min P; Qi C; Wang Q; Zhao M; Zhang Y; Du J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203692
[TBL] [Abstract][Full Text] [Related]
2. Sulfated polysaccharide of Sepiella Maindroni ink inhibits the migration, invasion and matrix metalloproteinase-2 expression through suppressing EGFR-mediated p38/MAPK and PI3K/Akt/mTOR signaling pathways in SKOV-3 cells.
Jiang W; Cheng Y; Zhao N; Li L; Shi Y; Zong A; Wang F
Int J Biol Macromol; 2018 Feb; 107(Pt A):349-362. PubMed ID: 28870748
[TBL] [Abstract][Full Text] [Related]
3. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.
Dai C; Xie Y; Zhuang X; Yuan Z
Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226
[TBL] [Abstract][Full Text] [Related]
4. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway.
Zhu H; Diao S; Lim V; Hu L; Hu J
Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187
[TBL] [Abstract][Full Text] [Related]
5. MMP9 activation triggered by epidermal growth factor induced FoxO1 nuclear exclusion in non-small cell lung cancer.
Pei J; Lou Y; Zhong R; Han B
Tumour Biol; 2014 Jul; 35(7):6673-8. PubMed ID: 24705809
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of ARK5 expression suppresses invasion of ovarian cancer cells.
Wang S; Li S; Wang H; Li W; Gao Y; Wang X; Fang C; Zhang B; Sun X; Li R; Shi W; Chen M; Shi L
Mol Med Rep; 2019 Apr; 19(4):2927-2934. PubMed ID: 30720082
[TBL] [Abstract][Full Text] [Related]
8. Sohlh2 inhibits human ovarian cancer cell invasion and metastasis by transcriptional inactivation of MMP9.
Zhang H; Hao C; Wang Y; Ji S; Zhang X; Zhang W; Zhao Q; Sun J; Hao J
Mol Carcinog; 2016 Jul; 55(7):1127-37. PubMed ID: 26153894
[TBL] [Abstract][Full Text] [Related]
9. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
10. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells.
Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L
Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269
[TBL] [Abstract][Full Text] [Related]
13. MICALL2 as a substrate of ubiquitinase TRIM21 regulates tumorigenesis of colorectal cancer.
Wen P; Wang H; Li Y; Sui X; Hou Z; Guo X; Xue W; Liu D; Wang Y; Gao J
Cell Commun Signal; 2022 Oct; 20(1):170. PubMed ID: 36307841
[TBL] [Abstract][Full Text] [Related]
14. Desmocollin 3 mediates follicle stimulating hormone-induced ovarian epithelial cancer cell proliferation by activating the EGFR/Akt signaling pathway.
Yang X; Wang J; Li WP; Jin ZJ; Liu XJ
Int J Clin Exp Pathol; 2015; 8(6):6716-23. PubMed ID: 26261554
[TBL] [Abstract][Full Text] [Related]
15. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines.
Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K
Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321
[TBL] [Abstract][Full Text] [Related]
16. Loss of RBPMS in ovarian cancer compromises the efficacy of EGFR inhibitor gefitinib through activating HER2/AKT/mTOR/P70S6K signaling.
Li M; Hu M; Wang Y; Xia Z; Li Z; Li J; Zheng D; Zheng X; Xi M
Biochem Biophys Res Commun; 2022 Dec; 637():348-357. PubMed ID: 36423381
[TBL] [Abstract][Full Text] [Related]
17. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Wang F; Xiao W; Sun J; Han D; Zhu Y
Tumour Biol; 2014 Sep; 35(9):8653-8. PubMed ID: 24867100
[TBL] [Abstract][Full Text] [Related]
19. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer.
Zhang L; Liu XL; Yuan Z; Cui J; Zhang H
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells.
Xi Y; Nie X; Wang J; Gao L; Lin B
Biomed Res Int; 2020; 2020():3607436. PubMed ID: 32309430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
